Factors Affecting Disease-Free Survival in Operated Nonmetastatic Gastrointestinal Stromal Tumors

dc.contributor.author Sakin, Abdullah
dc.contributor.author Can, Orcun
dc.contributor.author Arici, Serdar
dc.contributor.author Yasar, Nurgul
dc.contributor.author Geredeli, Caglayan
dc.contributor.author Demir, Cumhur
dc.contributor.author Cihan, Sener
dc.date.accessioned 2025-05-10T17:25:45Z
dc.date.available 2025-05-10T17:25:45Z
dc.date.issued 2019
dc.description Cihan, Sener/0000-0002-3960-4982; Can, Orcun/0000-0002-9400-105X; Arici, Serdar/0000-0003-2018-6554; Sakin, Abdullah/0000-0003-2538-8569; Geredeli, Caglayan/0000-0002-3982-7465 en_US
dc.description.abstract Background: Possibly originating from interstitial Cajal cells, gastrointestinal stromal tumors (GISTS) have variable biological behaviors. In this study, we aimed to examine the factors affecting the disease-free survival (DFS) in patients with GIST who underwent operation. Material and methods: The study included the patients who were followed up and treated for GIST in our oncology clinic between 2002 and 2017. The Armed Forces Institute of Pathology criteria (Miettinen risk score) were used for risk stratification of patients. Results: Seventy-four patients were included to the study, where female patients constituted 52.7%, and the median age was 56 (range: 24-83) y. Most common primary tumor location was the stomach (51.4%), followed by the small intestine (33.8%), colorectum (10.8%), and retroperitoneum (4.1%). Miettinen risk score showed 12 patients (16.7%) at very low risk, 15 patients (20.8%) at low risk, 18 patients (25%) at intermediate risk, and 27 patients (37.5%) at high risk. DFS was significantly lower in patients with small intestine involvement than in cases with stomach involvement (P = 0.004). DFS was significantly lower in patients at high risk than in patients with no high risk (P = 0.034). Small intestine localization (hazard ratio [HR], 8.98; 95% confidence interval [CI], 1.14-8.18), high-risk score (HR, 5.16; 95% CI, 1.42-12.75), c-kit positivity (HR, 0.24; 95% CI, 0.13-0.69), and adjuvant therapy (HR, 0.37; 95% CI, 0.20-0.92) were found to be the most significant factors affecting DFS. Conclusions: Our study showed negative effects of small intestine localization and high-risk category and positive effects of c-kit positivity and adjuvant therapy on DFS in patients with GIST who underwent operation. When a decision will be made in favor of adjuvant therapy, tumor localization and c-kit mutation should also be considered in addition to risk score. (C) 2019 Elsevier Inc. All rights reserved. en_US
dc.identifier.doi 10.1016/j.jss.2019.03.059
dc.identifier.issn 0022-4804
dc.identifier.issn 1095-8673
dc.identifier.scopus 2-s2.0-85064549580
dc.identifier.uri https://doi.org/10.1016/j.jss.2019.03.059
dc.identifier.uri https://hdl.handle.net/20.500.14720/11468
dc.language.iso en en_US
dc.publisher Academic Press inc Elsevier Science en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Gastrointestinal Stromal Tumor en_US
dc.subject Disease-Free Survival en_US
dc.subject Imatinib en_US
dc.subject Overall Survival en_US
dc.title Factors Affecting Disease-Free Survival in Operated Nonmetastatic Gastrointestinal Stromal Tumors en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Cihan, Sener/0000-0002-3960-4982
gdc.author.id Can, Orcun/0000-0002-9400-105X
gdc.author.id Arici, Serdar/0000-0003-2018-6554
gdc.author.id Sakin, Abdullah/0000-0003-2538-8569
gdc.author.id Geredeli, Caglayan/0000-0002-3982-7465
gdc.author.scopusid 55293011200
gdc.author.scopusid 57204774164
gdc.author.scopusid 57204771705
gdc.author.scopusid 24823118000
gdc.author.scopusid 55189913500
gdc.author.scopusid 19834529300
gdc.author.scopusid 19834529300
gdc.author.wosid Yaşar, Nurgül/Gpk-1197-2022
gdc.author.wosid Cihan, Şener/Aaw-1956-2021
gdc.author.wosid Can, Orçun/Agx-9627-2022
gdc.author.wosid Geredeli, Caglayan/Aan-4122-2020
gdc.author.wosid Arici, Serdar/Aan-4106-2020
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Sakin, Abdullah] Yuzuncu Yil Univ, Dept Med Oncol, Med Sch, Van, Turkey; [Can, Orcun; Arici, Serdar; Yasar, Nurgul; Geredeli, Caglayan; Demir, Cumhur; Cihan, Sener] Univ Hlth Sci, Okmeydani Training & Res Hosp, Dept Med Oncol, Istanbul, Turkey en_US
gdc.description.endpage 177 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.startpage 170 en_US
gdc.description.volume 241 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.pmid 31026795
gdc.identifier.wos WOS:000471137000025
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files